Cytodyn Inc (CYDY)

[TheBioTechG]

It's a shame that they having trouble enrolling patients in to their trials; however, this does not change the results of PRO 140. The activity today goes to show you how fickle your average investor is. Yes, their original timeline has been delayed by about a year, but if you're invested in CYDY, you're in it for the long. There could easily be a complete turn around in SP with the release of the abstract (and subsequent partnership), Charlie saying he is in the trial and doing well, or any number of different PRs regarding last patient enrollment or orphan drug status. PRO 140 has shown through clinical data that it is legitimate. Kudos to those who will be able to re-enter at a lower SP.